cartiheal
-
Financial
Smith+Nephew completes acquisition of novel cartilage regeneration technology for sports medicine knee repair
10 January 2024 – Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, announces that it has completed the acquisition of…
Read More » -
Financial
Smith+Nephew acquires novel cartilage regeneration technology for sports medicine knee repair
November 22, 2023 – Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces that it has entered into a…
Read More » -
Sports Medicine
CartiHeal Announces First Commercial Implantation of Agili-C™ in the US
Dr. Ken Zaslav KFAR SABA, Israel, July 26, 2023 /PRNewswire/ — CartiHeal Ltd., developer of implants for the treatment of cartilage and osteochondral defects…
Read More » -
Financial
Bioventus Completes CartiHeal Acquisition
DURHAM, N.C., July 12, 2022 (GLOBE NEWSWIRE) — Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for…
Read More » -
Financial
Bioventus Amends CartiHeal Acquisition Structure
DURHAM, N.C., June 21, 2022 (GLOBE NEWSWIRE) — Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for…
Read More » -
Financial
Bioventus Exercises Call Option to Acquire CartiHeal
DURHAM, N.C., April 04, 2022 (GLOBE NEWSWIRE) — Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for…
Read More » -
Regulatory
FDA approves CartiHeal’s Implant for the Treatment of Cartilage and Osteochondral Defects
Approval is based on results of a multicenter, randomized, open-labeled and controlled IDE clinical study that demonstrated the superiority of…
Read More » -
Extremities
CartiHeal Announces Pivotal Study Results Demonstrate Agili-C™ Superiority to Microfracture and Debridement for the Treatment of Cartilage and Osteochondral Defects
According to a Two-Year Randomized and Controlled Multinational IDE Study KFAR SABA, Israel, Aug. 3, 2021 /PRNewswire/ — CartiHeal Ltd, developer of Agili-C™,…
Read More » -
Regulatory
CartiHeal Receives FDA “Breakthrough Device Designation” for the novel Agili-C Implant
KFAR SABA, Israel, Oct. 12, 2020 /PRNewswire/ — CartiHeal, developer of Agili-C™, a proprietary implant for the treatment of cartilage lesions in arthritic…
Read More » -
Financial
Bioventus Makes $15 Million Equity Investment in CartiHeal with an Agreed Option Structure to Acquire Company Upon Milestone Achievements
July 16, 2020 KFAR SABA, Israel & DURHAM, N.C.–(BUSINESS WIRE)–CartiHeal, developer of the proprietary Agili™-C implant for the treatment of…
Read More » -
Biologics
CartiHeal Announces Positive Interim Analysis Results of Agili-C™ IDE Study
KFAR SABA, Israel, Dec. 9, 2019 /PRNewswire/ — CartiHeal, developer of Agili-C™, a proprietary implant for the treatment of cartilage lesions in arthritic…
Read More » -
Extremities
CartiHeal Performs First Agili-C™ Cartilage Repair Implantation Procedure in Maryland
Dr. Scopp performs first Agili-C™ cartilage repair implantation procedure in Maryland KFAR SABA, Israel, Oct. 15, 2019 /PRNewswire/ — CartiHeal, developer of Agili-C™,…
Read More » -
Extremities
CartiHeal Performs First Agili-C™ Cartilage Repair Implantation Procedure in Texas
KFAR SABA, Israel, Aug. 27, 2019 /PRNewswire/ — CartiHeal, developer of Agili-C™, a proprietary implant for the treatment of cartilage lesions in arthritic and…
Read More » -
Hospitals
CartiHeal Performs First Agili-C™ Cartilage Repair Implantation Procedures at Hospital for Special Surgery (HSS), New York, NY
KFAR SABA, Israel, Aug. 7, 2019 /CNW/ — CartiHeal, developer of Agili-C™, a proprietary implant for the treatment of cartilage lesions in…
Read More » -
Sports Medicine
CartiHeal Enrolls the 200th Patient in Its Pivotal Clinical Study in San Diego, CA
KFAR SABA, Israel, June 12, 2019 /PRNewswire/ — CartiHeal, developer of the Agili-C™ implant for treating cartilage and osteochondral defects in traumatic and…
Read More »